Profile data is unavailable for this security.
About the company
Abbisko Cayman Ltd is a China-based clinical-stage biopharmaceutical company. The Company is dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The Company owns two Core Product Candidates, ABSK011 and ABSK091, and 12 other pipeline product candidates. ABSK011 is a potent and highly selective small molecule inhibitor of fibroblast growth factor receptor 4 (FGFR4). ABSK091 is a molecularly targeted product candidate and a highly potent and selective inhibitor of FGFR subtypes 1, 2 and 3. The Company’s products are primarily being developed for hepatocellular carcinoma (HCC), urothelial cancer (UC) and gastric cancer (GC).
- Revenue in HKD (TTM)20.59m
- Net income in HKD-466.32m
- Incorporated2018
- Employees258.00
- LocationAbbisko Cayman LtdBuilding 3, No. 898Halei Road, Zhangjiang Hi-Tech ParkPudong New AreaSHANGHAI 200120ChinaCHN
- Phone+86 2 168912098
- Websitehttps://www.abbisko.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jacobio Pharmaceuticals Group Co Ltd | 68.63m | -388.03m | 1.55bn | 301.00 | -- | 1.34 | -- | 22.61 | -0.5019 | -0.5019 | 0.0888 | 1.46 | 0.0419 | -- | 5.21 | 228,017.00 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| Mabpharm Ltd | 94.18m | -226.21m | 1.63bn | 347.00 | -- | 7.35 | -- | 17.30 | -0.0549 | -0.0549 | 0.0228 | 0.0537 | 0.0893 | 0.1176 | 6.02 | 271,403.80 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Hua Medicine | 82.78m | -228.24m | 1.70bn | 177.00 | -- | 14.42 | -- | 20.53 | -0.2335 | -0.2335 | 0.0847 | 0.1117 | 0.0538 | 1.69 | 1.98 | 467,665.60 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -361.77m | 1.75bn | 210.00 | -- | 9.33 | -- | -- | -0.703 | -0.703 | 0.00 | 0.3646 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -1.97 | 0.4327 | -- | -- | -- | -5.25 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.24bn | 352.24m | 1.76bn | 1.14k | 4.99 | 0.5691 | 3.88 | 1.41 | 0.2343 | 0.2343 | 0.8278 | 2.06 | 0.3156 | 2.31 | 6.37 | 1,088,196.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
| Acotec Scientific Holdings Ltd | 511.99m | 15.65m | 2.06bn | 638.00 | 126.40 | 1.47 | 31.42 | 4.03 | 0.0521 | 0.0521 | 1.70 | 4.47 | 0.3136 | 0.7213 | 3.44 | 802,493.60 | 0.9589 | -- | 1.03 | -- | 79.65 | -- | 3.06 | -- | 9.12 | 2.75 | 0.1529 | -- | 19.80 | -- | -79.35 | -- | -- | -- |
| SinoMab Bioscience Ltd | 1.47m | -262.68m | 2.07bn | 233.00 | -- | 6.16 | -- | 1,406.45 | -0.258 | -0.258 | 0.0015 | 0.3086 | 0.0015 | -- | -- | -- | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -8.15 | 0.604 | -- | -- | -- | 14.45 | -- | -- | -- |
| Cutia Therapeutics | 148.70m | -2.12bn | 2.26bn | 298.00 | -- | 1.55 | -- | 15.21 | -18.26 | -18.26 | 0.7267 | 4.79 | -- | -- | -- | 498,997.00 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Abbisko Cayman Ltd | 20.59m | -466.32m | 2.40bn | 258.00 | -- | 1.12 | -- | 116.61 | -0.7205 | -0.7205 | 0.0318 | 3.05 | 0.0083 | -- | 1.40 | 79,822.70 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
| Peijia Medical Ltd | 476.63m | -424.12m | 2.49bn | 1.04k | -- | 1.01 | -- | 5.22 | -0.6245 | -0.6245 | 0.7017 | 3.62 | 0.1473 | 0.7773 | 9.51 | 458,302.80 | -13.11 | -34.08 | -14.94 | -36.90 | 73.76 | 71.62 | -88.99 | -448.75 | 6.92 | -- | 0.0886 | -- | 75.86 | -- | 3.75 | -- | -- | -- |
| Laekna Inc | 0.00 | -398.50m | 2.49bn | 89.00 | -- | 2.87 | -- | -- | -3.30 | -3.30 | 0.00 | 2.23 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -4.09 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
| MicroPort CardioFlow Medtech Corp | 363.28m | -509.49m | 2.70bn | 592.00 | -- | 1.07 | -- | 7.44 | -0.2156 | -0.2156 | 0.1537 | 1.05 | 0.1205 | 2.78 | 3.67 | 613,646.90 | -16.91 | -17.37 | -18.11 | -22.96 | 2.06 | -1.67 | -140.25 | -180.82 | 9.91 | -11.56 | 0.0293 | -- | 33.94 | -- | -3.77 | -- | -14.16 | -- |
| Golden Throat Holdings Group Co Ltd | 1.04bn | 270.30m | 2.74bn | 869.00 | 10.15 | 1.64 | 8.78 | 2.64 | 0.3656 | 0.3656 | 1.41 | 2.27 | 0.4181 | 4.82 | 1.85 | 1,195,356.00 | 10.88 | 11.00 | 15.85 | 15.63 | 72.57 | 72.79 | 26.02 | 24.67 | 2.48 | 34.74 | 0.21 | 82.96 | -3.09 | 6.73 | -11.04 | 19.61 | -- | 38.94 |
| HighTide Therapeutics Inc | 0.00 | -594.00m | 2.78bn | 66.00 | -- | 3.36 | -- | -- | -1.26 | -1.26 | -- | 1.61 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -0.3798 | 0.0229 | -- | -- | -- | -393.76 | -- | -- | -- |
| Frontage Holdings Corp | 2.03bn | 84.55m | 2.89bn | 1.76k | 34.71 | 1.08 | 7.98 | 1.42 | 0.0409 | 0.0409 | 0.9822 | 1.32 | 0.463 | 60.63 | 5.32 | 1,155,668.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Cryofocus Medtech Shanghai Co Ltd | 44.25m | -105.33m | 3.10bn | 392.00 | -- | 17.79 | -- | 70.14 | -0.4405 | -0.4405 | 0.185 | 0.7296 | -- | -- | -- | 112,873.30 | -- | -- | -- | -- | 75.83 | -- | -258.23 | -- | 4.08 | -- | 0.0597 | -- | 50.83 | -- | 13.13 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Abbisko Cayman Ltd's reporting currency: Hong Kong Dollar HKD
6.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Temasek Holdings Pte Ltd. (Investment Management)as of 23 Nov 2023 | 23.31m | 3.32% |
| UBS Asset Management (Hong Kong) Ltd.as of 29 Dec 2023 | 10.46m | 1.49% |
| BlackRock Advisors LLCas of 31 Mar 2024 | 5.94m | 0.85% |
| Fidelity Management & Research (Hong Kong) Ltd.as of 29 Feb 2024 | 4.80m | 0.68% |
| Invesco Hong Kong Ltd.as of 29 Feb 2024 | 2.02m | 0.29% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2023 | 555.00k | 0.08% |
| Schroder Investment Management (Hong Kong) Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
